Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $6,344 - $8,379
-170 Reduced 1.24%
13,515 $510,000
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $30,217 - $35,087
-608 Reduced 4.25%
13,685 $697,000
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $98,132 - $121,709
-1,822 Reduced 11.31%
14,293 $770,000
Q2 2022

Aug 15, 2022

BUY
$63.83 - $80.0 $6,191 - $7,760
97 Added 0.61%
16,115 $1.04 Million
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $7,377 - $8,361
-100 Reduced 0.62%
16,018 $1.29 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $74,221 - $81,145
-922 Reduced 5.41%
16,118 $1.3 Million
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $15,276 - $17,206
-200 Reduced 1.16%
17,040 $1.44 Million
Q4 2020

Feb 16, 2021

BUY
$75.39 - $82.36 $356,594 - $389,562
4,730 Added 37.81%
17,240 $1.38 Million
Q3 2020

Nov 16, 2020

BUY
$78.33 - $90.73 $413,582 - $479,054
5,280 Added 73.03%
12,510 $1.01 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $217,494 - $260,297
-2,765 Reduced 27.66%
7,230 $623,000
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $853,830 - $1.11 Million
-11,930 Reduced 54.41%
9,995 $811,000
Q3 2019

Nov 12, 2019

BUY
$81.4 - $89.78 $687,016 - $757,743
8,440 Added 62.59%
21,925 $1.92 Million
Q2 2019

Aug 13, 2019

SELL
$73.44 - $82.41 $717,508 - $805,145
-9,770 Reduced 42.01%
13,485 $1.1 Million
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $106,069 - $133,754
-1,645 Reduced 6.61%
23,255 $1.89 Million
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $1.53 Million - $1.94 Million
24,900 New
24,900 $1.64 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track London & Capital Asset Management LTD Portfolio

Follow London & Capital Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on London & Capital Asset Management LTD with notifications on news.